(Q63321521)
Statements
A Randomized, Single-blind (Investigator and Subject), Placebo-controlled, Single Ascending Dose Study Exploring the Preliminary Safety, Tolerability, and Pharmacokinetics of GSK1223249 Administered by Intravenous (IV) Infusion to Subjects With Relapsing Forms of Multiple Sclerosis, Not on Disease Modifying Therapy (English)
0 references
11 February 2010
0 references
26 August 2010
0 references
3
0 references
18 year
0 references
55 year
0 references